Cover Page

Cite item


In the article the current literature, devoted to the peculiarities of functioning of the thyroid gland in patients with HIV infection, is analyzed. Based on the analysis of literature data bases demonstrated the structure of thyroid function disorders in HIV-infected, as well as the mechanisms of the pathogenesis of these disorders. In the structure of thyroid function is dominated by hypothyroidism, euthyroid pathological syndrome, Graves' disease, for which the opportunistic infections are triggers immune activation.  It should be noted that the step of acquired immunodeficiency syndrome is accompanied by the development of inflammatory and neoplastic processes in the thyroid gland. Convincingly demonstrated the negative impact of highly active antiretroviral therapy in HIV-positive for the development of thyroid dysfunction, in connection which the expediency of forming risk groups and the timely correction of the projected thyroid diseases.


About the authors

E. V. Timofeeva

Scientific Center of Family Health and Human Reproduction Siberian Branch of Russian Academy of Medical Sciences, Irkutsk, Russian Federation

Author for correspondence.
Email: eve_gin@list.ru
PG student of the Federal State Budgetary Institution “Scientific Centre of the Family Health and Human Reproduction Problems” under the Siberian Branch of RAMS. Address: 16, Timiryazeva St., Irkutsk, 664003, tel.: (3952) 20-76-36 Russian Federation

O. Ya. Leshchenko

Scientific Center of Family Health and Human Reproduction Siberian Branch of Russian Academy of Medical Sciences, Irkutsk, Russian Federation

Email: loyairk@mail.ru
PhD, Head of the socially significant infections laboratory of the Federal State Budgetary Institution “Scientific Centre of the Family Health and Human Reproduction Problems” under the Siberian Branch of RAMS. Address: 16, Timiryazeva St., Irkutsk, 664003, tel.: (3952) 20-76-36 Russian Federation


  1. Bartlett D., Gallant D., Fam P. Klinicheskie aspekty VICh-infektsii. [Clinical Aspects of HIV Infection]. Мoscow, R.Valent, 2010. 490 p.
  2. Lobzin Yu.V. Rukovodstvo po infektsionnym boleznyam. Chast’ 2. [Infectious Diseases Manual. Part 2]. Saint-Petersburg, 2000. 300 p.
  3. Pokrovskii V.V., Yurin O.G., Belyaeva V.V. Klinicheskaya diagnostika i lechenie VICh-infektsii: prakticheskoe rukovodstvo. [Clinical Diagnostics and HIV Infection Treatment: Practice Guidelines]. Мoscow, GOU VUNPTs MZ RF, 2001. 96 p.
  4. Belyakov N.A., Bobkova M.R., Vinogradova A.N. Virus immunodefitsita cheloveka — meditsina: rukovodstvo dlya vrachei. [Human Immunodeficiency Virus — Medicine: Guidelines for Physicians]. Saint-Petersburg, Baltiiskii meditsinskii obrazovatel’nyi tsentr, 2011. 656 p.
  5. Varthakavi P.K. Thyroid dysfunction in HIV-AIDS. JAPI. 2009; 57: 503–504.
  6. Beltran S., Lescure F., Desailloud R. Increased prevalence of hypothyroidism among Human Immunodeficiency Virus-Infected patients: A need for screening. Clin. Infect. Dis. 2003; 37 (4): 579–583.
  7. Fontes R. Endocrine disorders in Brazilian patients with acquired immune deficiency syndrome. Clin. Infect. Dis. 2003; 37: 137–141.
  8. Highleyman L. HIV and Hormones. San Francisco AIDS Foundation. 2004; 16: 4.
  9. Langford D., Baron D., Valle L.D. Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation. Psychoneuroendocrinology. 2011; 36 (5): 710–719.
  10. Sanjay K., Hamby S. Human immunodeficiency virus and the endocrine system. Indian J. Endocrinol. Metab. 2011; 15 (4): 231–233.
  11. Sinha U., Sengupta N. Human immunodeficiency virus endocrinopathy. Indian J. Endocrinol. Metab. 2011; 15 (4): 251–260.
  12. Afhami S., Haghpanah V., Heshmat R. Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study. Infection. 2007; 5: 334–338.
  13. Bongiovanni M., Adorni F. Subclinical hypothyroidism in HIV-infected subjects. J. Antimicrob. Chemother. 2006; 58 (5):1086-1089.
  14. Hoffmann C.J., Brown T.T. Thyroid function abnormalities in HIV-infected patients. AIDS. 2007; 45: 488–494.
  15. Zandman-Goddard G., Shoenfeld Y. HIV and autoimmunity. Autoimmun. Rev. 2002; 1 (6): 329–337.
  16. Touzot M., Beller C. Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient. AIDS. 2006; 20: 1210–1212.
  17. Grappin M. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS. 2000; 14 (8): 1070–1075.
  18. Quirino T. Hypothyroidism in HIV-infected patients who have or have not received HAART. CID. 2004; 38 (4):596-597.
  19. Madeddu G., Spanu A., Chessa F. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin. Endocrinol. 2006; 64: 375–383.
  20. Nelson M., Powles T. Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J. AIDS. 2009; 50 (1): 113–114.
  21. Calza L., Manfredi R. Subclinical hypothyroidism in HIV-Infected patients receiving highly active antiretroviral therapy. AIDS. 2002; 31: 361-368.
  22. Collazos J., Ibarra S. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS.2003; 17 (5): 763–765.
  23. Jain G., Devpura G. Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adult. JAPI. 2009; 57: 508–510.
  24. Malik R., Hodgson H. The relationship between the thyroid gland and the liver. Quart. J. Med. 2002; 95 (9): 559–569.
  25. French M.A., Lewin S.R., Dykstra C. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res Hum Retroviruses. 2004; 20(2): 157-162.
  26. Wong K.H., Chow W.S. Clinical Hyperthyroidism in Chinese Patients with Stable HIV Disease. Clin Infect Dis. 2004; 39 (8): 1257-1259.
  27. Lewden C., Bonnet F. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. J Infect Dis. 2005; 37(6): 482-487.
  28. Shelburne S, Montes M. Immune reconstitution inflammatory syndrome: more answers, more questions. J. Antimicrob. Chemother. 2006; 57 (2): 167-170.
  29. Vos F., Pieters G., Keuter M. Graves' disease during immune reconstitution in HIV-infected patients treated with HAART. Scand J. Infect. Dis. 2006; 38(2): 124-126.
  30. Jimenez C., Moran S.A., Sereti I. Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid. 2004; 14(12): 1097-1102.
  31. Knysz B., Bolanowski M. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol. 2006; 19(1): 102-107.
  32. Chen F., Day S.L., Metcalfe R.A., Sethi G., Kapembwa M.S., Brook M.G., Churchill D. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore). 2005; 84(2): 98-106.
  33. Crum N.F., Ganesan A. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS. 2006; 20: 466-469.
  34. Freitas P., Bettencourt-Silva R. Changes in Thyroid Function in a HIV-1 Infected Population on Combined Antiretroviral Therapy. Endocr Rev. 2012; 33: 134-137.
  35. Rasul S., Delapenha R., Farhat F. Graves' Disease as a Manifestation of Immune Reconstitution in HIV-Infected Individuals after Initiation of Highly Active Antiretroviral Therapy. AIDS Res Treat. 2011; 7: 43-47.
  36. Desailloud R., Hober D. Viruses and thyroiditis: an update. Virol J. 2009; 6: 120-130.
  37. Pearce E.N., Farwell A.P. Thyroiditis. N Engl J Med. 2003; 26: 2646-2655.
  38. Oliveira B. Infectious and neoplastic disorders of the thyroid in AIDS patients: an autopsy study. Braz J Infect Dis. 2000; 4: 67–75.

Copyright (c) 1970 "Paediatrician" Publishers LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies